Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
25.61
+2.11 (8.98%)
Mar 23, 2026, 4:00 PM EDT - Market closed
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $320.81 million as of March 24, 2026. Its market cap has increased by 615.83% in one year.
Market Cap
320.81M
Enterprise Value
227.40M
1-Year Change
615.83%
Ranking
Category
Stock Price
$25.61
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $320.81M, an increase of 76.82%. That is a compound annual growth rate of 10.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 419.04M | -13.82% |
| Dec 31, 2025 | 486.26M | 234.91% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immix Biopharma | 305.89M |
| Armata Pharmaceuticals | 304.81M |
| Bicycle Therapeutics | 303.23M |
| Crescent Biopharma | 300.37M |
| NovaBridge Biosciences | 295.15M |
| Neurogene | 295.08M |
| Foghorn Therapeutics | 293.50M |
| Climb Bio | 291.86M |